Evidence map›Paper›PMID 32432645›Full record

ArticleJAMA dermatology2020

Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host Disease.

Karl M Saardi, Rachel K Rosenstein, Milan J Anadkat, Robert G Micheletti, Adam I Schiffenbauer, Steven Z Pavletic, Edward W Cowen

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. AT1R Activating Autoantibodies in Hematopoietic Stem Cell Transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karl M SaardiDepartment of Dermatology, MedStar Washington Hospital Center/Georgetown University Hospital, Washington, DC.
Rachel K RosensteinDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
Milan J AnadkatWashington University School of Medicine in St Louis, Division of Dermatology, St Louis, Missouri.
Robert G MichelettiPerelman School of Medicine, Department of Dermatology, University of Pennsylvania, Philadelphia.
Adam I SchiffenbauerDivision of Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, Maryland.
Steven Z PavleticImmune Deficiency Cell Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Edward W CowenDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

Funding

NIH Chronic GVHD Study GroupZIABC011743 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PAVLETIC, STEVEN · 2016 to 2025
$10.2M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAntibodies, AntinuclearCalcinosisChronic DiseaseFemaleGraft vs Host DiseaseHumansMaleMiddle AgedRetrospective StudiesRisk FactorsSkin DiseasesSkin TransplantationAntibodies, Antinuclear

Identifiers

PMID32432645
PMCPMC7344382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.